Gary B. Gordon insider trades
Open-market stock purchases and sales by Gary B. Gordon, Director at TriSalus Life Sciences, Inc, from SEC Form 4 filings since Jan 4, 2021.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +4%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 15, 2026 | TLSI TriSalus Life Sciences, Inc | Bought | $24.6K |
| May 14, 2026 | TLSI TriSalus Life Sciences, Inc | Bought (not open market) | — |
| May 14, 2026 | TLSI TriSalus Life Sciences, Inc | Bought (not open market) | — |
| May 14, 2026 | TLSI TriSalus Life Sciences, Inc | Bought (not open market) | — |
| Feb 23, 2026 | TLSI TriSalus Life Sciences, Inc | Bought | $40K |